Author

Gillian Corbett

Observed names: Corbett, Gillian, G CORBETT, G. CORBETT, G. Corbett

Observed institutions: Western General Hospital, Waikato Hospital, Tauranga Hospital

OpenAlex ID: A5006096720

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial

2020 · Jeff P Sharman, Miklos Egyed, et al. · The Lancet · 670

Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia

2022 · Jeff P. Sharman, Miklos Egyed, et al. · Leukemia · 225

ELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

2019 · Jeff P. Sharman, Versha Banerji, et al. · Blood · 67

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations

2024 · Nigel H. Russell, Charlotte Wilhelm-Benartzi, et al. · Journal of Clinical Oncology · 58

Sodium valproate in combination with ganciclovir induces lysis of EBV‐infected lymphoma cells without impairing EBV‐specific T‐cell immunity

2009 · K. JONES, J. NOURSE, et al. · International Journal of Laboratory Hematology · 30

Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study

2017 · Hang Quach, Liam Fernyhough, et al. · British Journal of Haematology · 27

Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Elevate-TN four-year follow up.

2021 · Jeff Porter Sharman, Miklos Egyed, et al. · Journal of Clinical Oncology · 23

Significance of Thrombocytosis

1983 · G CORBETT, D J Perry · The Lancet · 21

Lower-Dose Lenalidomide and Dexamethasone Reduces Toxicity without Compromising Efficacy In Patients with Relapsed/Refractory Myeloma, Who Are Aged ≥60 Years or Have Renal Impairment: Planned Interim Results of a Prospective Multicentre Phase II Trial

2010 · Hang Quach, Liam Fernyhough, et al. · Blood · 10

Correction: Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia

2024 · Jeff P. Sharman, Miklos Egyed, et al. · Leukemia · 3

Lower Dose Lenalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma Who Are Aged 60 Years or over and/or at Risk of Myelosuppression: Final Analysis of the Revlite Trial and Matched Comparison to the MM009 and MM010 Trials

2015 · Hang Quach, Simon Harrison, et al. · Blood · 2

Poster: CLL-139: Acalabrutinib ± Obinutuzumab vs Obinutuzumab + Chlorambucil in Treatment-Naïve Chronic Lymphocytic Leukemia: ELEVATE-TN 4-Year Follow-up

2021 · Jeff P. Sharman, Miklos Egyed, et al. · Clinical Lymphoma Myeloma & Leukemia · 1

CLL-139: Acalabrutinib ± Obinutuzumab vs Obinutuzumab + Chlorambucil in Treatment-Naïve Chronic Lymphocytic Leukemia: ELEVATE-TN 4-Year Follow-up

2021 · Jeff P. Sharman, Miklos Egyed, et al. · Clinical Lymphoma Myeloma & Leukemia · 1

Lower Dose Lenalidomide-Dexamethasone is Less Toxic and does not Compromise Efficacy for Patients with Relapsed/Refractory multiple myeloma who are aged ≥60 years and/or with renal impairment and/or with thrombocytopenia

2015 · H. Quach, S. Harrison, et al. · Clinical Lymphoma Myeloma & Leukemia · 1

Maternal Factors and Host-Microbe Interactions in Spontaneous Preterm Birth

2026 · Corbett, Gillian · Research Repository UCD (University College Dublin)

Incidence of Non-Melanoma Skin Cancers in Patients with Chronic Lymphocytic Leukaemia: A Retrospective Study in a Bay of Plenty, New Zealand Population

2021 · Andrew Weston, Marie Hughes, et al. · Blood

Ibrutinib vs Clorambucilo-Burger-2015-e-pub

2016 · Burger Ja, Alessandra Tedeschi, et al.

Works count: 17

Citation count: 1,139

H-index: 9

I10-index: 9